Update on malignant hyperthermia. Symposium organised in collaboration with the European Malignant Hyperthermia Group (EMHG)
ESAIC Academy. Rueffert H. 06/05/17; 184086; 138
Topic: General Anaesthesia
Abstract
Discussion Forum (0)
Rate & Comment (0)
Sub Committee Pharmacology in collaboration with ESA Specialist Society - European Malignant Hyperthermia Group
This symposium will feature a combination of the ways that malignant hyperthermia can impact on clinical practice. The first lecture will cover unusual presentations of MH which illustrate why the condition is still associated with significant morbidity and mortality. The second lecture covers one of the most frequent reasons for patients and anaesthetists to contact an MH Centre - how to manage the labouring MH patient. The third talk will examine the controversies surrounding the association between neuromuscular disorders and MH.
Sub Committee Pharmacology in collaboration with ESA Specialist Society - European Malignant Hyperthermia Group
This symposium will feature a combination of the ways that malignant hyperthermia can impact on clinical practice. The first lecture will cover unusual presentations of MH which illustrate why the condition is still associated with significant morbidity and mortality. The second lecture covers one of the most frequent reasons for patients and anaesthetists to contact an MH Centre - how to manage the labouring MH patient. The third talk will examine the controversies surrounding the association between neuromuscular disorders and MH.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}